Vanessa Vaillancourt

Oncology, rare disease and women’s health · LinkedIn, X, Instagram and Facebook · Executive voice and patient stories · Medical, legal and regulatory review

Science captures attention. Human stories make it matter.
I turn complex healthcare and scientific ideas into clear, compelling content that connects with people across digital and social channels.

Available for full-time, freelance and contract opportunities across healthcare and consumer health.

Copywriting

Executive ghostwriting

Patient storytelling

Disease education

Video scripts

Campaign toolkits

Editorial development

AP, Chicago and AMA style

Less corporate speak. More actual point of view.

On social, executive thought leadership should sound like a person, not a press release. It starts with a perspective worth sharing, then finds the right form to bring it to life. Here, one interview became a short video, with captions and social copy that carried the leader’s voice beyond the conference.

The work

In his own words, straight from the conference floor

Executive voice
Filming guide
Rapid turnaround
Short-form video

In small cell lung cancer, survival rates have not changed dramatically in decades now…

On-screen copy

A short clip cut from an on-site interview gave the leader fresh content for his account while the conversation was still timely.

The thinking

Questions drafted for a filming guide produced a quote captured in an on-site interview at a conference. One idea carried the message: after years of limited progress, there is real hope on the horizon. A quick turnaround got the video up during the event, and kinetic captions keep the 16-second vertical video readable with the sound off.

Project details

Channel: X (@AmgenOncology) and the leader’s own account
Goal: Give a leader timely content in his own voice
My role: Concept, copywriting, on-screen copy and edit direction

On-screen copy

In small cell lung cancer, survival rates have not changed dramatically in decades now…
It’s very clear that we need to change the natural history of the disease.

Caption as published

Oncologists may soon have a new weapon in their arsenal to attack small cell lung cancer. @Amgen developed a potential targeted therapy that empowers a patient’s own immune system to seek out and help fight cancer cells. 🔗 Learn more.